Page last updated: 2024-09-03

cholestane-3,5,6-triol and Hyperlipoproteinemia Type II

cholestane-3,5,6-triol has been researched along with Hyperlipoproteinemia Type II in 1 studies

*Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Church, HJ; Cooper, JA; Wu, HY	1

Other Studies

1 other study(ies) available for cholestane-3,5,6-triol and Hyperlipoproteinemia Type II

Article	Year
Cholestane-3β, 5α, 6β-triol: Further insights into the performance of this oxysterol in diagnosis of Niemann-Pick disease type C. Molecular genetics and metabolism, 2020, Volume: 130, Issue:1 Topics: Adolescent; Adult; Aged; Biomarkers; Child; Child, Preschool; Cholestanols; Cholesterol; Chromatography, Liquid; Enzyme Replacement Therapy; Fibroblasts; Homozygote; Humans; Hyperlipoproteinemia Type II; Infant; Infant, Newborn; Limit of Detection; Middle Aged; Niemann-Pick Disease, Type C; Oxysterols; Sensitivity and Specificity; Tandem Mass Spectrometry; Wolman Disease	2020

Article

Year

Cholestane-3β, 5α, 6β-triol: Further insights into the performance of this oxysterol in diagnosis of Niemann-Pick disease type C.

Molecular genetics and metabolism, 2020, Volume: 130, Issue:1

Topics: Adolescent; Adult; Aged; Biomarkers; Child; Child, Preschool; Cholestanols; Cholesterol; Chromatography, Liquid; Enzyme Replacement Therapy; Fibroblasts; Homozygote; Humans; Hyperlipoproteinemia Type II; Infant; Infant, Newborn; Limit of Detection; Middle Aged; Niemann-Pick Disease, Type C; Oxysterols; Sensitivity and Specificity; Tandem Mass Spectrometry; Wolman Disease

2020